Difference between revisions of "Journal:Methods for quantification of cannabinoids: A narrative review"

From CannaQAWiki
Jump to navigationJump to search
(Saving and adding more.)
(Saving and adding more.)
Line 299: Line 299:
====HPLC-ESI-qTOF/MS====
====HPLC-ESI-qTOF/MS====
HPLC-electrospray ionization-quadrupole-time-of-flight mass spectrometry (HPLC-ESI-qTOF/MS) is very effective in identifying complex and common compounds and can identify the main component of a sample, in addition to enhancing the signal-to-noise ratio in the peaks. Citti ''et al.''<ref name="CittiMedicinal16" /> analyzed cannabinoid concentrations in olive oil, ethanol, and supercritical CO<sub>2</sub> and found that UV-DAD and qTOF detectors produced similar results, thus suggesting that these two detection systems are equally useful in cannabinoid analysis. Pellati ''et al.''<ref name="PellatiNew18" /> and Brighenti ''et al.''<ref name="BrighentiDevelop17" /> used HPLC-ESI/MS both in positive and negative ion mode for the analysis of cannabinoids. By developing HPLC methods, they improved resolution, peak shape, and separation performance, together with the improvement of the ionization in HPLC-ESI/MS.<ref name="PellatiNew18" /><ref name="BrighentiDevelop17" />
HPLC-electrospray ionization-quadrupole-time-of-flight mass spectrometry (HPLC-ESI-qTOF/MS) is very effective in identifying complex and common compounds and can identify the main component of a sample, in addition to enhancing the signal-to-noise ratio in the peaks. Citti ''et al.''<ref name="CittiMedicinal16" /> analyzed cannabinoid concentrations in olive oil, ethanol, and supercritical CO<sub>2</sub> and found that UV-DAD and qTOF detectors produced similar results, thus suggesting that these two detection systems are equally useful in cannabinoid analysis. Pellati ''et al.''<ref name="PellatiNew18" /> and Brighenti ''et al.''<ref name="BrighentiDevelop17" /> used HPLC-ESI/MS both in positive and negative ion mode for the analysis of cannabinoids. By developing HPLC methods, they improved resolution, peak shape, and separation performance, together with the improvement of the ionization in HPLC-ESI/MS.<ref name="PellatiNew18" /><ref name="BrighentiDevelop17" />
====HPLC-MS/MS====
A solution to analyzing coeluting cannabinoids is to use HPLC-[[tandem mass spectrometry]] (HPLC-MS/MS).<ref name="Aizpurua-OlaizolaIdent14" /><ref name="CittiPharm18" /> Aizpurua-Olaizola ''et al.''<ref name="Aizpurua-OlaizolaIdent14" /> utilized HPLC-MS/MS to identify THCA, THC, CBD, THCV, CBG, and CBN in 30 ''Cannabis'' plant varieties. Using the results from their study, they were able to distinguish ''Cannabis'' plants grown indoors from those grown outdoors. These results suggest that HPLC can be used to successfully determine several cannabinoid profiles and that this method can be used to distinguish between cannabis varieties and growing conditions.<ref name="Aizpurua-OlaizolaIdent14" />
====LC-MS/MS with APCI====
Grauwiler ''et al.''<ref name="GrauwilerDevelop07">{{cite journal |title=Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of ''Cannabis sativa'' extracts |journal=Journal of Chromatogrophy B |author=Grauwiler, S.B.; Scholer, A.; Drewe, J. |volume=850 |issue=1–2 |pages=515–22 |year=2007 |doi=10.1016/j.jchromb.2006.12.045 |pmid=17236827}}</ref> developed a method to simultaneously detect five cannabinoids in human plasma and urine using HPLC-MS/MS and [[atmospheric-pressure chemical ionization]] (APCI). Their method had a 25-minute runtime, with a 0.2 ng/mL lower limit of quantification on samples following human oral administration of 20 mg of THC. Although APCI methods are less sensitive than ESI methods, APCI methods were chosen instead of ESI methods because they produced fewer matrix effects. Limits of detection and limits of quantification were found to be acceptable even with APCI methods.<ref name="GrauwilerDevelop07" />
====UPLC-qTOF====
Ultra-performance liquid chromatography allows researchers to use a thinner column compared to HPLC, and it can be used for particles less than 2 μm, which leads to better separation with higher speed than conventional HPLC. For example, Aizpurua-Olaizola ''et al.''<ref name="Aizpurua-OlaizolaIdent14" /> identified seven unknown minor cannabinoids using UPLC-quadrupole-time-of-flight mass spectrometry (UPLC-qTOF). Jung ''et al.''<ref name="JungStudies09">{{cite journal |title=Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques |journal=Journal of Mass Spectrometry |author=Jung, J.; Meyer, M.R.; Maurer, H.H. et al. |volume=44 |issue=10 |pages=1423–33 |year=2009 |doi=10.1002/jms.1624 |pmid=19728318}}</ref> also implemented qTOF in their study to isolate and identify THCA and 12 of its metabolites in rat urine using LC-MS, LC-MS/MS, and LC-qTOF MS. The use of qTOF results in increased accuracy of the detected ions, and when analyzing extracts acquired from complex matrices using MS/MS, qTOF allows for increased cannabinoid specificity.<ref name="LeghissaARev18" />
Although MS offers many benefits, the use of qTOF mass spectrometers is ideal when trying to differentiate between two compounds with different compositions but the same nominal mass.<ref name="CittiPharm18" /> qTOF mass spectrometers can provide accurate mass identification with a threshold less than 5 ppm for precursor and product ions; this allows for differentiation between isomers of cannabinoids<ref name="LeghissaARev18" /><ref name="CittiPharm18" /> such as Δ8-tetrahydrocannabinol and Δ9-tetrahydrocannabinol, which have the same m/z because these cannot be differentiated by MS.<ref name="CittiPharm18" /> Such isomers may have different therapeutic properties and may need to be separated for manufacture, so it is important to adopt an analytical technique that can differentiate between them.
====Matrix-assisted laser desorption/ionization mass spectrometry====
[[Matrix-assisted laser desorption/ionization]] mass spectrometry (MALDI-MS) is a new method which has been used in some studies for comparison with usual methods such as LC-MS and GC-MS in identification of cannabinoid metabolites.<ref name="BeasleyDetect16">{{cite journal |title=Detection and Mapping of Cannabinoids in Single Hair Samples through Rapid Derivatization and Matrix-Assisted Laser Desorption Ionization Mass Spectrometry |journal=Analytical Chemistry |author=Beasley, E.; Francese, S.; Bassindale, T. |volume=88 |issue=20 |pages=10328-10334 |year=2016 |doi=10.1021/acs.analchem.6b03551 |pmid=27648476}}</ref> Recently, this method has attracted attention because, when compared to usual mentioned methods, the sample preparation is simpler, a narrower time frame of drug can be detected, and the sample amount is reduced. Beasley ''et al.''<ref name="BeasleyDetect16" /> have used MALDI-MS to detect the cannabinoids in a single hair sample. In this study, the MALDI instrument consisted of an MDS Sciex hybrid quadrupole time-of-flight mass spectrometer with an orthogonal MALDI ion source and a neodymium-doped yttrium aluminum garnet laser.
===LC and GC methods comparison===


==References==
==References==
Line 304: Line 322:


==Notes==
==Notes==
This presentation is faithful to the original, with only a few minor changes to presentation. Some grammar and punctuation was cleaned up to improve readability. In some cases important information was missing from the references, and that information was added. The original article lists references in alphabetical order; this wiki organizes them by order of appearance, by design. Several of the original citations had incorrect publication years; they were corrected for this version. One ref (Aminah Jatoi et al. 2002) didn't fit into the context of the article and appeared to be added in error; the presumably correct citation for Citti 2016 was used in its place for this version. A similar error was found for a Peschel and Politi citation (using Andreae et al. 2015) and for a Citti ''et al.'' 2018 citation (using Beal et al. 1995).
This presentation is faithful to the original, with only a few minor changes to presentation. Some grammar and punctuation was cleaned up to improve readability. In some cases important information was missing from the references, and that information was added. The original article lists references in alphabetical order; this wiki organizes them by order of appearance, by design. Several of the original citations had incorrect publication years; they were corrected for this version. One ref (Aminah Jatoi et al. 2002) didn't fit into the context of the article and appeared to be added in error; the presumably correct citation for Citti 2016 was used in its place for this version. A similar error was found for a Peschel and Politi citation (using Andreae ''et al.'' 2015), a Citti ''et al.'' 2018 citation (using Beal ''et al.'' 1995), a Aizpurua-Olaizola ''et al.'' citation (using Borgelt ''et al.'' 2013), and for a Jung ''et al.'' citation (using Brighenti ''et al.'' 2017).


<!--Place all category tags here-->
<!--Place all category tags here-->

Revision as of 00:17, 1 December 2020

Full article title Methods for quantification of cannabinoids: A narrative review
Journal Journal of Cannabis Research
Author(s) Lazarjani, Masoumeh P.; Torres, Stephanie; Hooker, Thom; Fowlie, Chris; Young, Owen; Seyfoddin, Ali
Author affiliation(s) Auckland University of Technology, Chapman University, ZeaCann Limited,
Primary contact Email: Online form
Year published 2020
Volume and issue 2
Article # 35
DOI 10.1186/s42238-020-00040-2
ISSN 2522-5782
Distribution license Creative Commons Attribution 4.0 International
Website https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-020-00040-2
Download https://jcannabisresearch.biomedcentral.com/track/pdf/10.1186/s42238-020-00040-2.pdf (PDF)
Emblem-important-yellow.svg This article should be considered a work in progress and incomplete. Consider this article incomplete until this notice is removed.

Abstract

Background: Around 144 cannabinoids have been identified in the Cannabis plant; among them tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most prominent ones. Because of the legal restrictions on cannabis in many countries, it is difficult to obtain standards to use in research; nonetheless, it is important to develop a cannabinoid quantification technique, with practical pharmaceutical applications for quality control of future therapeutic cannabinoids.

Method: To find relevant articles for this narrative review paper, a combination of keywords such as "medicinal cannabis," "analytical," "quantification," and "cannabinoids" were searched for in PubMed, EMBASE, MEDLINE, Google Scholar, and Cochrane Library (Wiley) databases.

Results: The most common cannabinoid quantification techniques include gas chromatography (GC) and high-performance liquid chromatography (HPLC). Gas chromatography is often used in conjunction with mass spectrometry (MS) or flame ionization detection (FID). The major advantage of GC is with the quantification of terpenes. However, for evaluating acidic cannabinoids, it needs to be derivatized. The main advantage of HPLC is the ability to quantify both acidic and neutral forms of cannabinoids without derivatization, which is often accomplished with MS or ultraviolet (UV) detectors.

Conclusion: Based on the information presented in this review, the ideal cannabinoid quantification method is HPLC paired with tandem mass spectrometry (MS/MS).

Introduction

Cannabis sativa L. is an annual herbaceous flowering plant indigenous to eastern Asia.[1] The phenotypes of Cannabis are highly variable, and the plant is accepted to have two subspecies: C. sativa and C. indica.[2][3] A third variety, C. ruderalis, has been identified as a Cannabis species; however, it is not broadly recognized as a specific subspecies of C. sativa.[2][4] The Cannabis plant has been used for its therapeutic properties for thousands of years, and it was introduced to Western medicine in the nineteenth century, until it was later outlawed in the U.S. from the mid-1930s.[5]

The medicinal compounds from Cannabis plants are mostly concentrated in the female flowers of this dioecious species.[4] The so-called resin is the source of a wide variety of terpenoids and cannabinoids.[4] The therapeutic properties of cannabis are attributed to cannabinoids.[6] Cannabinoids are found in the resin produced by the trichomes, which are widely distributed on both the male and female plants, though they are most highly concentrated on the female flowers of the cannabis plant.[1][7] Cannabinoids are terpenophenolic compounds unique to Cannabis.[2] To date, 144 cannabinoids have been identified.[6] The two cannabinoids most well known for their therapeutic properties are tetrahydrocannabinol (THC) and cannabidiol (CBD).[2][8] THC and CBD are the neutral homologs of tetrahydrocannabinolic acid (THCA) and cannabidiolic acid (CBDA), respectively.[8] A conventional classification model of cannabinoids is due to their chemical contents dividing them into eleven subclasses, including THC, CBD, cannabigerol (CBG), cannabichromene (CBC), cannabinol (CBN), (−)-Δ8-trans-tetrahydrocannabinol (Δ8-THC), cannabicyclol (CBL), cannabinodiol (CBND), cannabielsoin (CBE), cannabitriol (CBT), and "miscellaneous types."[9] (Fig. 1).


Fig1 Lazarjani BMCJournCannaRes2020 2.png

Fig. 1 The most common cannabinoids and their conversion pathway by decarboxylation because of heat or aging. CBGA can convert to CBDA and THCA by CBDA synthase and THCA synthase, respectively. CBGA: cannabigerolic acid, CBG: cannabigerol, CBDA: cannabidiolic acid, CBD: cannabidiol, THCA: tetrahydrocannabinolic acid, THC: tetrahyrocannabinol, CBN: cannabinol[10]

Because consumers have limited means to analyze the chemical composition of cannabis products, consumers may be inadvertently purchasing products with undesired properties given that different cannabinoids produce different effects.[11] As a result, it is important to implement methods of quality control so that consumers can be certain that what they are consuming will have the desired effects.[4][11][12] As cannabis use becomes progressively accepted, it becomes increasingly important to quantify the cannabinoid profile and content of cannabis preparations to ensure the uniformity and quality of the preparations.[13]

A variety of analytical techniques have been developed for the quantification and qualification of cannabinoids and other compounds in the Cannabis plant. Advances in analytical methods have also resulted in detection of various additional compounds from cannabis extracts in the last decade (e.g., terpenes). The purpose of this literature review is to explore cannabinoid quantification techniques and subsequently suggest an optimal method for pharmaceutical-grade quantification.

Methods

To find relevant papers for this narrative review, many databases were reviewed over a period of eight months. A combination of keywords such as "medicinal cannabis," "analytical," "quantification," and "cannabinoids" were searched. PubMed, EMBASE, MEDLINE, Google Scholar, and Cochrane Library (Wiley) databases were searched for English language papers published from 1967 to 2019. In the next step, the results were then scrutinized to discard irrelevant papers. Those papers which were deemed relevant were subjected to more detailed analysis. In total, the number of papers read was about 75, including around 15 irrelevant papers.

Quantitative analysis of cannabinoids

Gas chromatography

Gas chromatography (GC) is one of the most commonly used chromatographic methods in quantitative cannabinoid analysis.[14] Gas chromatography is typically completed in under 20 minutes at up to 300 °C and makes use of stationary phases with low polarities, such as 5% diphenyl- and 95% dimethylpolysiloxane.[15] It is important to note that the total quantity of cannabinoids in a sample is the sum of the acidic and neutral components.[7] Because gas chromatography requires high column temperatures, the acidic cannabinoids undergo decarboxylation during transit through the column.[1][7][14] As such, acidic cannabinoids cannot be determined unless they are derivatized prior to analysis.[14] Not only does derivatization preserve cannabinoid structure, but it also causes cannabinoids to become more volatile, thus improving peak shape.[15] Dussy et al.[12] suggested calculating the amount of neutral and acidic cannabinoids separately in order to accurately determine the total cannabinoid content. Gas chromatography resolves cannabinoids, but detection on elution presents its own challenges and solutions.

GC- FID/MS

GC is normally coupled with mass spectrometry (MS) or flame ionization detection (FID) to detect and quantify cannabinoids[7][14] (see Tables 1 and 2). MS employs standardized electron ionization to fragment analytes, permitting the use of compound libraries to identify the parent analyte. FID provides more accurate cannabinoid quantification because it makes use of relatively cheap authentic standards, whereas MS usually requires equivalent deuterated standards, which are expensive and not available for all cannabinoids.[7][14]

Table 1. An overview to the key properties of a common GC-MS method for analyzing cannabinoids with a capillary column, used in six different studies. LOD = limit of detection, LOQ = limit of quantification. am stands for mass and z is charge number of ions; for GC-MS, z is almost always 1, so m/z is mass.
Key capillary column properties Cannabinoids analyzed Oven process Carrier gas Range LOD LOQ References
Silica capillary column coated with DB1 16 major cannabinoids Initial 10 °C, 108 °C /min, up to 280 °C. Hold for 30 min. Helium N/A N/A N/A [16]
VA5MS capillary column coated with DB1 Δ9-THC, CBD, CBN, CBG, THCA, CBGA, CBDA Initial 100 °C, 108 °C /min, up to 280 °C. Hold for 30 min. Helium N/A N/A N/A [14]
5% Cross-linked phenylmethylsiloxane capillary column CBG, CBD, CBDA, CBN, CBGA, THC, CBC, THCA Initial 50 °C, 6 °C /min, up to 300 °C. Hold for 4 min. (3 min solvent delay was applied.) Helium m/za 40–500 N/A N/A [17]
5% Diphenyl-/95% dimethylpolysiloxane capillary column THC-THCA Initial 70 °C, 40 °C /min up to 180 °C, then 10 °C/min up to 300 °C. Hold for 6.25 min. Helium 0.10–4.00% (w/w) 0.03% (w/w) 10% (w/w) [18]
Cross-linked poly-5% diphenyl-/95% dimethylpolysiloxane capillary column CBDA-CBD Initial 45 °C, 2 °C /min, up t0 100°C, then 5 °C /min up to 250 °C. Hold for 5 min. Helium m/z 40–500 N/A N/A [19]
5% Cross-linked phenylmethylsiloxane capillary column CBG, CBD, THC, CBC, CBN Initial 50 °C, 6 °C/min, up to 300 °C. Hold for 4 min. (3 min solvent delay was applied.) Helium m/z 40–400 N/A N/A [20]
Table 2. Key properties of a GC-FID method for analyzing cannabinoids with a capillary column, used in four different studies.
Capillary column properties Cannabinoids analyzed Oven process Carrier gas References
DB5 capillary column THCA, CBGA, CBCA, THC, CBG, CBC Initial 60 °C, 3 °C/min, up to 240 °C. Hold for 5 min. Nitrogen [21]
Silica capillary column coated with DB1 Δ9-THC, CBD, CBN, CBG, THCA, CBGA, CBDA Initial 100 °C, 108 °C/min, up to 280 °C. Hold for 30 min. Nitrogen [14]
DB5 5% diphenyl-/95% dimethylpolysiloxane capillary column THC-THCA Initial 200 °C, 10 °C/min, up to 300 °C. Hold for 2 min. Helium [18]
Cross-linked poly-5% diphenyl-/95% dimethylpolysiloxane capillary column CBDA-CBD Initial 45 °C, 2 °C/min, up to 100 °C then 5 °C/min, up to 250 °C. Hold for 5 min. Helium [19]

As shown in Table 1, all referenced instances used helium as the carrier gas in GC-MS, as it provides higher efficacy than other gases such as hydrogen and nitrogen. In each study, according to the compound of interest, different columns and different protocols were used. The high temperature in injection point is the con for preserving acidic forms of cannabinoids. To validate all the quantification methods, two parameters should be detected. Limit of detection (LOD) and limit of quantification (LOQ). These two parameters show the lowest concentration of the compound of interest that can be reliably measured by an analytical method (which are mentioned in Table 1 for the GC-MS method).

Leghissa et al.[22] used multiple reaction monitoring (MRM) analysis of cannabis from a surrogate hops matrix by GC-MS with triple quadrupole mass spectrometry for the first time. They used silylated cannabinoids to avoid the decarboxylation process due to high temperature typically found in the GC injection port. They found that this method is applicable to cannabinoid analysis from plant materials and cannabis products. The main achievement of their study is that, in this method, because the risk of interference from the essential oils and waxes is reduced, the extraction needs less sample preparation in the laboratory, compared to other techniques like solid-phase extraction (SPE).

In another study, GC with vacuum ultraviolet spectroscopy (GC-VUV) was used. The detection of cannabinoids and the cannabinoid metabolites was fast and simple, making it ideal for use in rapid detection of them even without having a baseline for cannabinoids for comparison. This method has just one disadvantage, which is a high LOD. Due to this drawback, detecting analytes in biological matrices cannot be accomplished without pretreatments.[23]

Two-dimensional gas chromatography

Experience has shown that one-dimensional gas chromatography does not provide enough resolution to analyze complex cannabinoid mixtures.[8] Two-dimensional gas chromatography (GC × GC) has been found to be preferable over one-dimensional GC for analyzing complex mixtures, such as cannabis extracts, in that it reveals more sample components.[13][24][25] Additionally, GC × GC produces two sets of retention data for sample constituents, which can greatly aid analyte identification.[24]

In the previous Table 2, nitrogen and helium are shown as the carrier gases. In many studies, it has been proved that nitrogen has the best efficacy, but it is time consuming. On the other hand, by using helium, the process is rapid and efficient, but the price is not affordable. The onitial and end temperatures, the type of columns, and the drawbacks are almost similar to GC-MS.

Liquid chromatography (LC)

High-performance liquid chromatography (HPLC) is a commonly used liquid chromatography (LC) technique in quantitative cannabinoid analysis[14] (Table 3). The most common columns used in HPLC consist of C18 stationary phases[7][15] and methanol with 0.1% formic acid or water with 0.1% formic acid as mobile phases.[15] C18 columns have high resolution and can differentiate between cannabinoids.[7][26] The use of formic acid in the mobile phase provides better peak shape and improved results, when compared with other mobile phases, as well as improved resolution in the chromatographic analysis.[26] In another example, Peschel and Politi[27] ran two HPLC assays to identify major and minor cannabinoids. Extract profiling was based on the main cannabinoid (THC, CBD, CBG, and CBN) quantification and the presence of acids and flavones. In this research, they found good resolutions of THCA, CBGA, CBDA, THCVA, THC, CBG, CBD, and THCV by HPLC.

Table 3. Key properties of common HPLC methods for analyzing cannabinoids, used in eight different studies. LOD = limit of detection, LOQ = limit of quantification.
Column properties Mobile phase Cannabinoids analyzed Flow rate mL/min Injection volume Range LOD LOQ References
C18 column Methanol and water, acidified with formic acid THCA, CBGA, CBCA, THC, CBG, CBC 0.5 2 μL 200–400 nm N/A N/A [21]
C18 with a C18 guard column Methanol and water, acidified with formic acid 16 major cannabinoids 0.3 Not stated 280–650 nm N/A N/A [16]
C18 with a C18 guard column Methanol and water, acidified with formic acid Δ9-THC, CBD, CBN, CBG, THCA, CBGA, CBDA 1.5 Not stated 200–400 nm N/A N/A [14]
C18 column 0.1% formic acid in both (A) H2O and (B) ACN CBDA, CBGA, CBD, CBG 0.4 3 μL 2.5–200 (μg/mL) 0.5–0.8 (μg/mL) 1.8–2.5 (μg/mL) [28]
RP18 end-capped column with a guard column 15% of acetic acid in water and methanol CBG, CBD, CBDA, CBN, CBGA, THC, CBC, THCA 1.5 50 μL 220–280 nm N/A N/A [17]
C18 column 0.1% formic acid in both (A) H2O and (B) ACN CBDA-CBD 0.4 3 μL >  0.999 0.4–0.1 μg/mL 1.3–0.3 μg/mL [19]
Silica column, with guard column Hexane/2-propanol/dimethyl propane (1000/5/1, v/v/v) N/A 1.0 20 mL 200–440 nm N/A N/A [29]
C18 end capped column with guard column 15% of acetic acid in water and methanol CBG, CBD, THC, CBC, CBN 1.5 50 μL 220–280 nm N/A N/A [20]

From Table 3, it is clearly obvious that C18 is the most popular column, as mentioned earlier. The main difference between HPLC and GC is the operating temperature. That is why HPLC is used when preserving the acidic form of cannabinoids matters. The only disadvantage of HPLC is its inability to analyze volatile compounds like terpenes.

HPLC-MS/UV/DAD

Different detection techniques can be used in conjunction with HPLC to analyze cannabinoids. Common detection methods include mass spectrometry (MS) and ultraviolet (UV) absorbance (190 to 400 nm)[5][15], with UV detection being much less expensive and more straightforward than MS detection.[15] Acidic cannabinoids show absorption peaks at around 270 nm and 310 nm, while neutral cannabinoids show absorption peaks at about 220 nm.[16][26] Citti et al.[26] developed a rapid HPLC technique with UV detection (HPLC-UV) to qualify and quantify major cannabinoids (CBDA, CBD, CBN, THC, and THCA) in cannabis extracts. However, absorption profiles from UV detection do not contain enough information to be used in isolation to accurately identify cannabinoids.[15] Much more information can be obtained by diode array detection (DAD), which covers the visible and UV spectrum. DAD can help to improve specificity because acidic and neutral cannabinoids have different absorption spectrums.[26][15] A use case can be found with Peschel and Politi[27], who used HPLC-DAD to differentiate between Cannabis sativa chemotypes, extracts of different polarity, and to profile extracts.

Nonetheless, all light absorbance detectors lack the specificity of MS[7][15], which is particularly useful in analyzing extracts from complex matrices such as cannabis. However, some cannabinoids, such as CBG and CBD are difficult to separate using UV detection, especially in concentrations greater than 10% in the extract.[1][7] In the case of CBG and CBD, MS is preferred because it can differentiate between different cannabinoids based on the m/z value of their molecular ion.[7] The m/z value is not always unique, however; in an ongoing study, Citti et al.[7] found five cannabinoids with the same m/z of 315.2294; this value matches that of THC and CBD in Bediol oil and ethanol extracts. Because some of these cannabinoids coelute, analysis of these compounds is difficult.

HPLC-ESI-qTOF/MS

HPLC-electrospray ionization-quadrupole-time-of-flight mass spectrometry (HPLC-ESI-qTOF/MS) is very effective in identifying complex and common compounds and can identify the main component of a sample, in addition to enhancing the signal-to-noise ratio in the peaks. Citti et al.[26] analyzed cannabinoid concentrations in olive oil, ethanol, and supercritical CO2 and found that UV-DAD and qTOF detectors produced similar results, thus suggesting that these two detection systems are equally useful in cannabinoid analysis. Pellati et al.[19] and Brighenti et al.[28] used HPLC-ESI/MS both in positive and negative ion mode for the analysis of cannabinoids. By developing HPLC methods, they improved resolution, peak shape, and separation performance, together with the improvement of the ionization in HPLC-ESI/MS.[19][28]

HPLC-MS/MS

A solution to analyzing coeluting cannabinoids is to use HPLC-tandem mass spectrometry (HPLC-MS/MS).[5][7] Aizpurua-Olaizola et al.[5] utilized HPLC-MS/MS to identify THCA, THC, CBD, THCV, CBG, and CBN in 30 Cannabis plant varieties. Using the results from their study, they were able to distinguish Cannabis plants grown indoors from those grown outdoors. These results suggest that HPLC can be used to successfully determine several cannabinoid profiles and that this method can be used to distinguish between cannabis varieties and growing conditions.[5]

LC-MS/MS with APCI

Grauwiler et al.[30] developed a method to simultaneously detect five cannabinoids in human plasma and urine using HPLC-MS/MS and atmospheric-pressure chemical ionization (APCI). Their method had a 25-minute runtime, with a 0.2 ng/mL lower limit of quantification on samples following human oral administration of 20 mg of THC. Although APCI methods are less sensitive than ESI methods, APCI methods were chosen instead of ESI methods because they produced fewer matrix effects. Limits of detection and limits of quantification were found to be acceptable even with APCI methods.[30]

UPLC-qTOF

Ultra-performance liquid chromatography allows researchers to use a thinner column compared to HPLC, and it can be used for particles less than 2 μm, which leads to better separation with higher speed than conventional HPLC. For example, Aizpurua-Olaizola et al.[5] identified seven unknown minor cannabinoids using UPLC-quadrupole-time-of-flight mass spectrometry (UPLC-qTOF). Jung et al.[31] also implemented qTOF in their study to isolate and identify THCA and 12 of its metabolites in rat urine using LC-MS, LC-MS/MS, and LC-qTOF MS. The use of qTOF results in increased accuracy of the detected ions, and when analyzing extracts acquired from complex matrices using MS/MS, qTOF allows for increased cannabinoid specificity.[15]

Although MS offers many benefits, the use of qTOF mass spectrometers is ideal when trying to differentiate between two compounds with different compositions but the same nominal mass.[7] qTOF mass spectrometers can provide accurate mass identification with a threshold less than 5 ppm for precursor and product ions; this allows for differentiation between isomers of cannabinoids[15][7] such as Δ8-tetrahydrocannabinol and Δ9-tetrahydrocannabinol, which have the same m/z because these cannot be differentiated by MS.[7] Such isomers may have different therapeutic properties and may need to be separated for manufacture, so it is important to adopt an analytical technique that can differentiate between them.

Matrix-assisted laser desorption/ionization mass spectrometry

Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) is a new method which has been used in some studies for comparison with usual methods such as LC-MS and GC-MS in identification of cannabinoid metabolites.[32] Recently, this method has attracted attention because, when compared to usual mentioned methods, the sample preparation is simpler, a narrower time frame of drug can be detected, and the sample amount is reduced. Beasley et al.[32] have used MALDI-MS to detect the cannabinoids in a single hair sample. In this study, the MALDI instrument consisted of an MDS Sciex hybrid quadrupole time-of-flight mass spectrometer with an orthogonal MALDI ion source and a neodymium-doped yttrium aluminum garnet laser.

LC and GC methods comparison

References

  1. ↑ 1.0 1.1 1.2 1.3 De Backer, B.; Debrus, B.; Lebrun, P. et al. (2009). "Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material". Journal of Chromatography B 877 (32): 4115–24. doi:10.1016/j.jchromb.2009.11.004. PMID 19932642. 
  2. ↑ 2.0 2.1 2.2 2.3 Hillig, K.W.; Mahlberg, P.G. (2004). "A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae)". American Journal of Botany 91 (6): 966-75. doi:10.3732/ajb.91.6.966. PMID 21653452. 
  3. ↑ Knight, G.; Hansen, S.; Connor, M. et al. (2010). "The results of an experimental indoor hydroponic Cannabis growing study, using the 'Screen of Green' (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis". Forensic Science International 202 (1–3): 36–44. doi:10.1016/j.forsciint.2010.04.022. PMID 20462712. 
  4. ↑ 4.0 4.1 4.2 4.3 Fischedick, J.T.; Van Der Kooy, F.; Verpoorte, R. (2010). "Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor". Chemical & Pharmaceutical Bulletin 58 (2): 201–7. doi:10.1248/cpb.58.201. PMID 20118579. 
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 Aizpurua-Olaizola, O.; Omar, J.; Navarro, P. et al. (2014). "Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry". Analytical and Bioanalytical Chemistry 406 (29): 7549-60. doi:10.1007/s00216-014-8177-x. PMID 25338935. 
  6. ↑ 6.0 6.1 Hazekamp, A.; Choi Y.H.; Verpoorte, R. (2004). "Quantitative analysis of cannabinoids from Cannabis sativa using 1H-NMR". Chemical and Pharmaceutical Bulletin 52 (6): 718–21. doi:10.1248/cpb.52.718. PMID 15187394. 
  7. ↑ 7.00 7.01 7.02 7.03 7.04 7.05 7.06 7.07 7.08 7.09 7.10 7.11 7.12 7.13 7.14 Citti, C.; Braghiroli, D.; Vandelli, M.A. et al. (2018). "Pharmaceutical and biomedical analysis of cannabinoids: A critical review". Journal of Pharmaceutical and Biomedical Analysis 147: 565–79. doi:10.1016/j.jpba.2017.06.003. PMID 28641906. 
  8. ↑ 8.0 8.1 8.2 Aizpurua-Olaizola, O.; Soydaner, U.; Öztürk, E. et al. (2016). "Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes". Journal of Natural Products 79 (2): 324-31. doi:10.1021/acs.jnatprod.5b00949. PMID 26836472. 
  9. ↑ Berman, P.; Futoran, K.; Lewitus, G.M. et al. (2018). "A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis". Scientific Reports 8 (1): 14280. doi:10.1038/s41598-018-32651-4. PMC PMC6155167. PMID 30250104. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=PMC6155167. 
  10. ↑ Fathordoobady, F.; Singh, A.; Kitts, D.D. et al. (2019). "Hemp (Cannabis sativa L.) Extract: Anti-Microbial Properties, Methods of Extraction, and Potential Oral Delivery". Food Reviews International 35 (7): 664–84. doi:10.1080/87559129.2019.1600539. 
  11. ↑ 11.0 11.1 Fischedick, J.T.; Hazekamp, A.; Erkelens, T. et al. (2010). "Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes". Phytochemistry 71 (17–18): 2058–73. doi:10.1016/j.phytochem.2010.10.001. PMID 21040939. 
  12. ↑ 12.0 12.1 Dussy, F.E.; Hamberg, C.; Luginbühl, M. et al. (2005). "Isolation of Delta9-THCA-A from hemp and analytical aspects concerning the determination of Delta9-THC in cannabis products". Forensic Science International 149 (1): 3–10. doi:10.1016/j.forsciint.2004.05.015. PMID 15734104. 
  13. ↑ 13.0 13.1 Omar, J.; Olivares, M.; Amigo, J.M. et al. (2014). "Resolution of co-eluting compounds of Cannabis sativa in comprehensive two-dimensional gas chromatography/mass spectrometry detection with Multivariate Curve Resolution-Alternating Least Squares". Talanta 121: 273–80. doi:10.1016/j.talanta.2013.12.044. PMID 24607138. 
  14. ↑ 14.0 14.1 14.2 14.3 14.4 14.5 14.6 14.7 14.8 Hazekamp, A.; Simons, R.; Peltenburg-Looman, A. et al. (2004). "Preparative Isolation of Cannabinoids from Cannabis sativa by Centrifugal Partition Chromatography". Journal of Liquid Chromatography & Related Technologies 27 (15): 2421–39. doi:10.1081/JLC-200028170. 
  15. ↑ 15.00 15.01 15.02 15.03 15.04 15.05 15.06 15.07 15.08 15.09 15.10 Leghissa, A.; Hildenbrand, Z.L.; Schug, K.A. (2018). "A review of methods for the chemical characterization of cannabis natural products". Journal of Separation Science 41 (1): 398-415. doi:10.1002/jssc.201701003. PMID 28986974. 
  16. ↑ 16.0 16.1 16.2 Hazekamp, A.; Peltenburg, A.; Verpoorte, R. et al. (2005). "Chromatographic and Spectroscopic Data of Cannabinoids from Cannabis sativa L.". Journal of Liquid Chromatography & Related Technologies 28 (15): 2361–82. doi:10.1080/10826070500187558. 
  17. ↑ 17.0 17.1 Namdar, D.; Mazuz, M; Ion, A. et al. (2018). "Variation in the compositions of cannabinoid and terpenoids in Cannabis sativa derived from inflorescence position along the stem and extraction methods". Industrial Crops and Products 113: 376–82. doi:10.1016/j.indcrop.2018.01.060. 
  18. ↑ 18.0 18.1 Casiraghi, A.; Roda, G.; Casagni, E. et al. (2018). "Extraction Method and Analysis of Cannabinoids in Cannabis Olive Oil Preparations". Planta Medica 84 (4): 242-249. doi:10.1055/s-0043-123074. PMID 29202510. 
  19. ↑ 19.0 19.1 19.2 19.3 19.4 Pellati, F.; Brighenti, V.; Sperlea, J. et al. (2018). "New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp)". Molecules 23 (10): 2639. doi:10.3390/molecules23102639. PMC PMC6222702. PMID 30322208. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=PMC6222702. 
  20. ↑ 20.0 20.1 Namdar, D.; Charuvi, D.; Ajjampura, V. et al. (2019). "LED lighting affects the composition and biological activity of Cannabis sativa secondary metabolites". Industrial Crops and Products 132: 177–85. doi:10.1016/j.indcrop.2019.02.016. 
  21. ↑ 21.0 21.1 Romano, L.L.; Hazekamp, A. (2013). "Cannabis oil: Chemical evaluation of an upcoming cannabis-based medicine". Cannabinoids 1 (1): 1–11. https://www.cannabis-med.org/index.php?tpl=cannabinoids&id=276&lng=en&red=cannabinoidslist. 
  22. ↑ Leghissa, A.; Hildenbrand, Z.L.; Foss, F.W. et al. (2018). "Determination of cannabinoids from a surrogate hops matrix using multiple reaction monitoring gas chromatography with triple quadrupole mass spectrometry". Journal of Separation Science 41 (2): 459–68. doi:10.1002/jssc.201700946. PMID 29094798. 
  23. ↑ Leghissa, A.; Smuts, J.; Qiu, C. et al. (2018). "Detection of cannabinoids and cannabinoid metabolites using gas chromatography with vacuum ultraviolet spectroscopy". Separation Science Plus 1 (1): 37–42. doi:10.1002/sscp.201700005. 
  24. ↑ 24.0 24.1 Dallüge, J.; Beens, J.; Th Brinkman, U.A. (2003). "Comprehensive two-dimensional gas chromatography: a powerful and versatile analytical tool". Journal of Chromatography A 1000 (1–2): 69–108. doi:10.1016/s0021-9673(03)00242-5. 
  25. ↑ Gröger, T.; Schäffer, M.; Pütz, M. et al. (2008). "Application of two-dimensional gas chromatography combined with pixel-based chemometric processing for the chemical profiling of illicit drug samples". Journal of Chromatography A 1200 (1): 8–16. doi:10.1016/j.chroma.2008.05.028. PMID 18539290. 
  26. ↑ 26.0 26.1 26.2 26.3 26.4 26.5 Citti, C.; Ciccarella, G.; Braghiroli, D. et al. (2016). "Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method". Journal of Pharmaceutical and Biomedical Analysis 128: 201–09. doi:10.1016/j.jpba.2016.05.033. PMID 27268223. 
  27. ↑ 27.0 27.1 Peschel, W.; Politi, M. (2015). "¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification". Talanta 140: 150–65. doi:10.1016/j.talanta.2015.02.040. PMID 26048837. 
  28. ↑ 28.0 28.1 28.2 Brighenti, V.; Pellati, F.; Steinbach, M. et al. (2017). "Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp)". Journal of Pharmaceutical and Biomedical Analysis 143: 228–36. doi:10.1016/j.jpba.2017.05.049. PMID 28609672. 
  29. ↑ Oomah, B.D.; Busson, M.; Godfrey, D.V. et al. (2002). "Characteristics of hemp (Cannabis sativa L.) seed oil". Fod Chemistry 76 (1): 33–43. doi:10.1016/S0308-8146(01)00245-X. 
  30. ↑ 30.0 30.1 Grauwiler, S.B.; Scholer, A.; Drewe, J. (2007). "Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts". Journal of Chromatogrophy B 850 (1–2): 515–22. doi:10.1016/j.jchromb.2006.12.045. PMID 17236827. 
  31. ↑ Jung, J.; Meyer, M.R.; Maurer, H.H. et al. (2009). "Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques". Journal of Mass Spectrometry 44 (10): 1423–33. doi:10.1002/jms.1624. PMID 19728318. 
  32. ↑ 32.0 32.1 Beasley, E.; Francese, S.; Bassindale, T. (2016). "Detection and Mapping of Cannabinoids in Single Hair Samples through Rapid Derivatization and Matrix-Assisted Laser Desorption Ionization Mass Spectrometry". Analytical Chemistry 88 (20): 10328-10334. doi:10.1021/acs.analchem.6b03551. PMID 27648476. 

Notes

This presentation is faithful to the original, with only a few minor changes to presentation. Some grammar and punctuation was cleaned up to improve readability. In some cases important information was missing from the references, and that information was added. The original article lists references in alphabetical order; this wiki organizes them by order of appearance, by design. Several of the original citations had incorrect publication years; they were corrected for this version. One ref (Aminah Jatoi et al. 2002) didn't fit into the context of the article and appeared to be added in error; the presumably correct citation for Citti 2016 was used in its place for this version. A similar error was found for a Peschel and Politi citation (using Andreae et al. 2015), a Citti et al. 2018 citation (using Beal et al. 1995), a Aizpurua-Olaizola et al. citation (using Borgelt et al. 2013), and for a Jung et al. citation (using Brighenti et al. 2017).

Retrieved from "https://www.cannaqa.wiki/index.php?title=Journal:Methods_for_quantification_of_cannabinoids:_A_narrative_review&oldid=16134"